References
- Hetland A, Carr DB. Medications and impaired driving. Ann Pharmacother. 2014;48(4):494-506. doi: 10.1177/1060028014520882.
- Duquet N. Drugs and driving. J Pharm Belg. 2013;(2):4-11.
- Kelly E, Darke S, Ross J. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev. 2004;23:319-44. doi: 10.1080/09595230412331289482.
- Orriols L, Salmi LR, Philip P, Moore N, Delorme B, Castot A, Lagarde E. The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf. 2009;18(8):64758. doi: 10.1002/pds.1763.
- Del Río MC, Alvarez FJ. Medication and fitness to drive. Pharmacoepidemiol Drug Saf. 2003;12(5):389-94. doi: 10.1002/ pds.806.
- Alvarez FJ, Del Río MC. Medicinal drugs and driving: from research to clinical practice. Trends Pharmacol Sci. 2002;23:441–3. doi: 10.1016/ s0165-6147(02)02083-7.
- Walsh JM, Verstraete AG, Huestis MA, Mørland J. Guidelines for research on drugged driving. Addiction. 2008;103(8):1258-68. doi: 10.1111/j.1360-0443.2008.02277.x.
- Rosso GL, Feola M, Rubinetto MP, Petti N, Rubinetto L. Professional drivers and psychoactive substances consumption: results from medical surveillance at the workplace in Piedmont region. G Ital Med Lav Ergon. 2011;33(Suppl 3):203-6. doi: 10.5772/38234.
- Girotto E, Guidoni CM, González AD, Mesas AE, Andrade SM. Continued use of drugs and working conditions among truck drivers. Cien Saude Colet. 2016;21(12):3769-76. doi: 10.1590/1413-812320152112.24212015.
- Girotto E, Mesas AE, de Andrade SM, Birolim MM. Psychoactive substance use by truck drivers: a systematic review. Occup Environ Med. 2014;71(1):71-6. doi: 10.1136/oemed-2013-101452.
- Williamson A. Predictors of psychostimulant use by long-distance truck drivers. Am J Epidemiol. 2007;166(11):1320-6. doi: 10.1093/aje/ kwm205.
- Kagashe G, Seleman K. Knowledge, attitude and practice of commercial drivers in Dar es Salaam with regard to medicines that impair driving. Trop J Pharm Res. 2009;8(4):297-302. doi: 10.4314/tjpr. v8i4.45220.
- Bernhoft IM, Steentoft A, Johansen SS, Klitgaard NA, Larsen LB, Hansen LB. Drugs in injured drivers in Denmark. Forensic Sci Int. 2005;150(2-3):181-9. doi: 10.1016/j.forsciint.2004.12.039.
- Janssen NB, Oort FJ, Fockens P, Willems DL, de Haes HC, Smets EM. Under what conditions do patients want to be informed about their risk of a complication? A vignette study. J Med Ethics. 2009;35(5):27682. doi: 10.1136/jme.2008.025031.
- International Pharmaceutical Federation. FIP statement of professional standards: the supply of medicines affecting driving performance. J Pain Palliat Care Pharmacother. 2005;19(2):55-7.
- European Monitoring Centre for Drugs and Drug Addiction. Driving under the influence of drugs, alcohol and medicines in Europe — findings from the DRUID project. Luxembourg: Publications Office of the European Union, 2012.
- Monteiro SP, van Dijk L, Verstraete AG, Alvarez FJ, Heissing M, de Gier JJ. Predictor for patient knowledge and reported behaviors regarding driving under the influence of medicines: a multi-country survey. BMC Public Health. 2012;12:59. doi: 10.1186/1471-2458-12-59
- Af Wåhlberg AE, Barraclough P, Freeman J. The Driver Behaviour Questionnaire as accident predictor; a methodological re-meta-analysis. J Safety Res. 2015;55:185-212. doi: 10.1016/j.jsr.2015.08.003.
- Stephens AN, Fitzharris M. Validation of the Driver Behaviour Questionnaire in a representative sample of drivers in Australia. Accid Anal Prev. 2016;86:186-98. doi: 10.1016/j.aap.2015.10.030.
- Cordazzo ST, Scialfa CT, Ross RJ. Modernization of the Driver Behaviour Questionnaire. Accid Anal Prev. 2016;87:83-91. doi: 10.1016/j.aap.2015.11.016.
- DeVellis RF. Scale development: theory and applications (applied social research methods). 3rd edition. London: SAGE, 2011.
- Kazuko O, Goro F, Makoto K, Ritsu K. Patterns of use, knowledge, and perceived effects of sedating medication on driving: a questionnaire survey of Japanese drivers who use sedating medication. Transport Res Part F Traffic Psychology Behav. 2018;54:276-89. doi: 10.1016/j.trf.2018.02.009
- Antonić R, Alimpić D, Pešić M, Vezmar Kovačević S, Miljković B. Drugs and safe driving – how much do our drivers know? Accessed August 2018. at: http://www.fip.org/abstracts?page=abstracts&action=item&item=7786
- Łuczak A, Tarnowski A. Validation of selected temperament and personality questionnaires for diagnosing drivers’ aptitude for safe driving: a Polish study. Accid Anal Prev. 2014;70:293-300. doi: 10.1016/j.aap.2014.04.001.
- Veldhuijzen DS, van Wijck AJ, Verster JC, Kalkman CJ, Kenemans JL, Olivier B, et al. The impact of chronic pain patients’ psychotropic drug knowledge and warning labels on the decision whether to drive a car or not. Traffic Inj Prev. 2006;7(4):360-4. doi: 10.1080/15389580600943005.
- Fierro I, Gómez-Talegón T, Alvarez FJ. The Spanish pictogram on medicines and driving: the population’s comprehension of and attitudes towards its use on medication packaging. Accid Anal Prev. 2013;50:1056-61. doi: 10.1016/j.aap.2012.08.009.
- Monteiro S, Huiskes R, van Dijk L, van Weert J, de Gier J. How effective are pictograms in communicating risk about driving-impairing medicines? Traffic Inj Prev. 2013;14(3):299-308. doi: 10.1080/15389588.2012.710766.
- Sigona N, Williams KG. Driving under the influence, public policy, and pharmacy practice. J Pharm Pract. 2015;28(1):119-23. doi: 10.1177/0897190014549839.
- Janković SM. Translation, adjustment and evaluation of reliability and validity of the questionnaires. In: Research Design. 1st ed. Kragujevac: Medrat, 2016:108-14.
- Koppel S, Stephens AN, Charlton JL, Di Stefano M, Darzins P, Odell M, et al. The Driver Behaviour Questionnaire for older drivers: do errors, violations and lapses change over time? Accid Anal Prev. 2018;113:1718. doi: 10.1016/j.aap.2018.01.036.